Page last updated: 2024-10-20

phosphorylethanolamine and Muscle Disorders

phosphorylethanolamine has been researched along with Muscle Disorders in 2 studies

phosphorylethanolamine: RN given refers to parent cpd; structure
O-phosphoethanolamine : The ethanolamine mono-ester of phosphoric acid, and a metabolite of phospholipid metabolism. This phosphomonoester shows strong structural similarity to the inhibitory neurotransmitter GABA, and is decreased in post-mortem Alzheimer's disease brain.

Research Excerpts

ExcerptRelevanceReference
"Pyridoxine-sensitive seizures characterize severe forms of infantile HPP."1.46Neuromuscular features of hypophosphatasia. ( Fonta, C; Salles, JP, 2017)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fonta, C1
Salles, JP1
Redmond, OM1
Bell, E1
Stack, JP1
Dervan, PA1
Carney, DN1
Hurson, B1
Ennis, JT1

Other Studies

2 other studies available for phosphorylethanolamine and Muscle Disorders

ArticleYear
Neuromuscular features of hypophosphatasia.
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2017, Volume: 24, Issue:5S2

    Topics: Adult; Alkaline Phosphatase; Animals; Biomarkers; Brain Diseases; Chronic Pain; Disease Models, Anim

2017
Tissue characterization and assessment of preoperative chemotherapeutic response in musculoskeletal tumors by in vivo 31P magnetic resonance spectroscopy.
    Magnetic resonance in medicine, 1992, Volume: 27, Issue:2

    Topics: Adult; Aged; Bone Neoplasms; Chemotherapy, Adjuvant; Ethanolamines; Female; Glycerylphosphorylcholin

1992